Tingting Kuang

Tingting Kuang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Pharmacological Research
Verified
Journal Article
Open access
LWLijie Wang
Lijie Wang
KZKun Zhang
Kun Zhang
YZYujiao Zeng
Yujiao Zeng
YLYuting Luo
Yuting Luo
JPJiayan Peng
Jiayan Peng
GFGang Fan
Gang Fan
Metabolic diseases, such as type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD) and obesity, have become a major public health problem worldwide. In recent years, most research on the role of gut microbes in metabolic diseases has focused on bacteria, whereas fungal microbes have been neglected. This review aims to provide a comprehensive overview of gut fungal alterations in T2DM, obesity, and NAFLD, and to discuss the mechanisms associated with disease development. In addition, several novel strategies targeting gut mycobiome and/or their metabolites to improve T2DM, obesity and NAFLD, including fungal probiotics, antifungal drugs, dietary intervention, and fecal microbiota transplantation, are critically discussed. The accumulated evidence suggests that gut mycobiome plays an important role in the occurrence and development of metabolic diseases. The possible mechanisms by which the gut mycobiome affects metabolic diseases include fungal-induced immune responses, fungal-bacterial interactions, and fungal-derived metabolites. Candida albicans, Aspergillus and Meyerozyma may be potential pathogens of metabolic diseases because they can activate the immune system and/or produce harmful metabolites. Moreover, Saccharomyces boulardii, S. cerevisiae, Alternaria, and Cochliobolus fungi may have the potential to improve metabolic diseases. The information may provide an important reference for the development of new therapeutics for metabolic diseases based on gut mycobiome.


19 May 2020 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
NLNing Li
Ning Li
QLQiuyue Li
Qiuyue Li
JBJinrong Bai
Jinrong Bai
KCKe Chen
Ke Chen
HYHailing Yang
Hailing Yang
GFGang Fan
Gang Fan
This study was first and systematically conducted to evaluate the hypoxia response of the brain, heart, lung, liver, and kidney of mice exposed to an animal hypobaric chamber. First, we examined the pathological damage of the above tissues by Hematoxylin & eosin (H&E) staining. Secondly, biochemical assays were used to detect oxidative stress indicators such as superoxide dismutase (SOD), malondialdehyde (MDA), reduced glutathione (GSH), and oxidized glutathione (GSSG). Finally, the hypoxia compensation mechanism of tissues was evaluated by expression levels of hypoxia-inducible factor 1 alpha (HIF-1α), erythropoietin (EPO), and vascular endothelial growth factor (VEGF). During the experiment, the mice lost weight gradually on the first 3 days, and then, the weight loss tended to remain stable, and feed consumption showed the inverse trend. H&E staining results showed that there were sparse and atrophic neurons and dissolved chromatin in the hypoxia group. And hyperemia occurred in the myocardium, lung, liver, and kidney. Meanwhile, hypoxia stimulated the enlargement of myocardial space, the infiltration of inflammatory cells in lung tissue, the swelling of epithelial cells in hepatic lobules and renal tubules, and the separation of basal cells. Moreover, hypoxia markedly inhibited the activity of SOD and GSH and exacerbated the levels of MDA and GSSG in the serum and five organs. In addition, hypoxia induced the expression of HIF-1α, EPO, and VEGF in five organs. These results suggest hypoxia leads to oxidative damage and compensation mechanism of the brain, heart, lung, liver, and kidney in varying degrees of mice.

23 November 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YLYuzhou Liu
Yuzhou Liu
ZFZige Feng
Zige Feng
YHYao Hu
Yao Hu
XXXinmei Xu
Xinmei Xu
TKTingting Kuang
Tingting Kuang
YLYue Liu
Yue Liu

15 November 2019 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
QLQiuyue Li
Qiuyue Li
HYHailing Yang
Hailing Yang
WWWenxiang Wang
Wenxiang Wang
NLNing Li
Ning Li
XZXuemei Zou
Xuemei Zou
TKTingting Kuang
Tingting Kuang

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XZXuemei Zou
Xuemei Zou
HYHailing Yang
Hailing Yang
QLQiuyue Li
Qiuyue Li
NLNing Li
Ning Li
YHYa Hou
Ya Hou
TKTingting Kuang
Tingting Kuang
Brassica rapa L., a traditional Tibetan medicine, has been wildly used for treating plateau disease. Polysaccharide is an important chemical component in B. rapa. The present study aimed to evaluate the effect of B. rapa polysaccharide (BRP) against acute high‐altitude hypoxia (AHH) induced brain injury and its metabolic mechanism. The rats were randomly divided into six groups: control group, AHH group, Hongjingtian oral liquid group, and three BRP groups (38, 75, and 150 mg/kg/d). Serum levels of superoxide dismutase (SOD), malondialdehyde (MDA), glutathione (GSH), oxidized glutathione (GSSG), and lactate dehydrogenase (LDH) were detected by commercial biochemical kits. Hippocampus and cortex histopathological changes were observed by H&E staining and Nissl staining. Neuronal apoptosis was observed by TUNEL staining. The protein and gene expression of Caspase‐3, Bax, Bcl‐2, p‐PI3K, PI3K, p‐Akt, Akt, HIF‐1α, microRNA 210, ISCU1/2, and COX10 were detected by western blotting and qRT‐PCR. Then, a brain metabolomics method based on UPLC‐Q‐Exactive‐MS was performed to discover potential biomarkers and analyze metabolic pathways. It was found that BRP decreased levels of MDA, LDH, and GSSG, increased GSH and SOD, reduced the pathological changes, inhibited apoptosis, and activated the PI3K/Akt/HIF‐1α signaling pathway as evidenced by increased phosphorylation of PI3K and Akt, enhanced protein expression of HIF‐1α and gene levels of microRNA210, ISCU1/2, and COX10. Furthermore, 15 endogenous potential biomarkers were identified in the brain through metabolomics analysis. BRP can regulate 7 potential biomarkers and the corresponding metabolic pathways were mainly associated with pyruvate metabolism and glycolysis/gluconeogenesis. Collectively, BRP has a clear protective effect on AHH‐induced brain injury and its mechanisms may be related to ameliorate oxidative stress injury, inhibit apoptosis by activating PI3K/Akt/HIF‐1α signaling pathway, and reverse metabolic pathway disturbances.